"Term","Overlap","P.value","Adjusted.P.value","Old.P.value","Old.Adjusted.P.value","Odds.Ratio","Combined.Score","Genes"
"Spinocerebellar ataxia type 12 ORPHA:98762","3/101",0.00206243076032719,0.244619063633053,0,0,12.9300911854103,79.9580031218518,"B3GAT1;SLC4A10;GFAP"
"Multiple synostoses syndrome ORPHA:3237","3/103",0.00218102923416408,0.244619063633053,0,0,12.6702127659574,77.6425365947916,"LRRN3;CD248;ADAMTS6"
"Pleomorphic salivary gland adenoma ORPHA:454821","2/100",0.0259489619459531,0.244619063633053,0,0,8.44047619047619,30.8214426622313,"POLR3G;ADAMTS6"
"Congenital membranous nephropathy due to fetomaternal anti-neutral endopeptidase alloimmunization ORPHA:69063","2/101",0.0264315192050236,0.244619063633053,0,0,8.35479797979798,30.3546359095748,"CD248;DEFA1"
"Gamma-aminobutyric acid transaminase deficiency ORPHA:2066","2/101",0.0264315192050236,0.244619063633053,0,0,8.35479797979798,30.3546359095748,"B3GAT1;SLC4A10"
"KRT1-related diffuse nonepidermolytic keratoderma ORPHA:530838","2/101",0.0264315192050236,0.244619063633053,0,0,8.35479797979798,30.3546359095748,"ZNF683;FGFBP2"
"Craniorachischisis ORPHA:63260","2/101",0.0264315192050236,0.244619063633053,0,0,8.35479797979798,30.3546359095748,"CACHD1;CD248"
"Bothnia retinal dystrophy ORPHA:85128","2/101",0.0264315192050236,0.244619063633053,0,0,8.35479797979798,30.3546359095748,"B3GAT1;GFAP"
"Occipital encephalocele ORPHA:268823","2/101",0.0264315192050236,0.244619063633053,0,0,8.35479797979798,30.3546359095748,"CACHD1;CD248"
"MME-related autosomal dominant Charcot Marie Tooth disease type 2 ORPHA:497757","2/101",0.0264315192050236,0.244619063633053,0,0,8.35479797979798,30.3546359095748,"CD248;DEFA1"
"EAST syndrome ORPHA:199343","2/101",0.0264315192050236,0.244619063633053,0,0,8.35479797979798,30.3546359095748,"B3GAT1;GFAP"
"Early-onset parkinsonism-intellectual disability syndrome ORPHA:2379","2/101",0.0264315192050236,0.244619063633053,0,0,8.35479797979798,30.3546359095748,"B3GAT1;SLC4A10"
"Charcot-Marie-Tooth disease type 2T ORPHA:495274","2/101",0.0264315192050236,0.244619063633053,0,0,8.35479797979798,30.3546359095748,"CD248;DEFA1"
"Spinocerebellar ataxia type 43 ORPHA:497764","2/101",0.0264315192050236,0.244619063633053,0,0,8.35479797979798,30.3546359095748,"CD248;DEFA1"
"Hypohidrosis-electrolyte imbalance-lacrimal gland dysfunction-ichthyosis-xerostomia syndrome ORPHA:528105","2/101",0.0264315192050236,0.244619063633053,0,0,8.35479797979798,30.3546359095748,"B3GAT1;DEFA1"
"Hypoparathyroidism-sensorineural deafness-renal disease syndrome ORPHA:2237","2/101",0.0264315192050236,0.244619063633053,0,0,8.35479797979798,30.3546359095748,"ZNF683;FGFBP2"
"Ichthyosis hystrix of Curth-Macklin ORPHA:79503","2/101",0.0264315192050236,0.244619063633053,0,0,8.35479797979798,30.3546359095748,"ZNF683;FGFBP2"
"Susceptibility to respiratory infections associated with CD8alpha chain mutation ORPHA:169085","2/101",0.0264315192050236,0.244619063633053,0,0,8.35479797979798,30.3546359095748,"ZNF683;FGFBP2"
"Pseudohypoaldosteronism type 2D ORPHA:300525","2/101",0.0264315192050236,0.244619063633053,0,0,8.35479797979798,30.3546359095748,"LRRN3;B3GAT1"
"Megalencephalic leukoencephalopathy with subcortical cysts ORPHA:2478","2/102",0.026917726401911,0.244619063633053,0,0,8.27083333333333,29.898816321571,"B3GAT1;GFAP"
"Microcephaly-polymicrogyria-corpus callosum agenesis syndrome ORPHA:171703","2/102",0.026917726401911,0.244619063633053,0,0,8.27083333333333,29.898816321571,"ZNF683;FGFBP2"
"Isolated congenital anosmia ORPHA:88620","2/102",0.026917726401911,0.244619063633053,0,0,8.27083333333333,29.898816321571,"B3GAT1;SLC4A10"
"NON RARE IN EUROPE: Tourette syndrome ORPHA:856","2/103",0.0274075630593293,0.244619063633053,0,0,8.18853135313531,29.4536255008379,"LRRN3;SLC4A10"
"Ollier disease ORPHA:296","2/103",0.0274075630593293,0.244619063633053,0,0,8.18853135313531,29.4536255008379,"TMEM37;GPT2"
"Rh deficiency syndrome ORPHA:71275","1/100",0.221926911560385,0.244619063633053,0,0,4.09214594928881,6.16034588762116,"DEFA1"
"Neu-Laxova syndrome ORPHA:2671","1/100",0.221926911560385,0.244619063633053,0,0,4.09214594928881,6.16034588762116,"GPT2"
"Bifunctional enzyme deficiency ORPHA:300","1/100",0.221926911560385,0.244619063633053,0,0,4.09214594928881,6.16034588762116,"TMEM37"
"Delta-beta-thalassemia ORPHA:231237","1/100",0.221926911560385,0.244619063633053,0,0,4.09214594928881,6.16034588762116,"DEFA1"
"Hb Bart's hydrops fetalis ORPHA:163596","1/100",0.221926911560385,0.244619063633053,0,0,4.09214594928881,6.16034588762116,"DEFA1"
"Hemoglobin H disease ORPHA:93616","1/100",0.221926911560385,0.244619063633053,0,0,4.09214594928881,6.16034588762116,"DEFA1"
"Hemoglobin Lepore-beta-thalassemia syndrome ORPHA:330032","1/100",0.221926911560385,0.244619063633053,0,0,4.09214594928881,6.16034588762116,"DEFA1"
"Hemoglobin M disease ORPHA:330041","1/100",0.221926911560385,0.244619063633053,0,0,4.09214594928881,6.16034588762116,"DEFA1"
"Osteogenesis imperfecta type 1 ORPHA:216796","1/100",0.221926911560385,0.244619063633053,0,0,4.09214594928881,6.16034588762116,"CD248"
"Hereditary persistence of fetal hemoglobin-beta-thalassemia syndrome ORPHA:46532","1/100",0.221926911560385,0.244619063633053,0,0,4.09214594928881,6.16034588762116,"DEFA1"
"Alpha-thalassemia-intellectual disability syndrome linked to chromosome 16 ORPHA:98791","1/100",0.221926911560385,0.244619063633053,0,0,4.09214594928881,6.16034588762116,"DEFA1"
"Hereditary spherocytosis ORPHA:822","1/100",0.221926911560385,0.244619063633053,0,0,4.09214594928881,6.16034588762116,"DEFA1"
"Simpson-Golabi-Behmel syndrome ORPHA:373","1/100",0.221926911560385,0.244619063633053,0,0,4.09214594928881,6.16034588762116,"CACHD1"
"Ehlers-Danlos/osteogenesis imperfecta syndrome ORPHA:230857","1/100",0.221926911560385,0.244619063633053,0,0,4.09214594928881,6.16034588762116,"CD248"
"Arthrochalasia Ehlers-Danlos syndrome ORPHA:1899","1/100",0.221926911560385,0.244619063633053,0,0,4.09214594928881,6.16034588762116,"CD248"
"Pitt-Hopkins-like syndrome ORPHA:221150","1/100",0.221926911560385,0.244619063633053,0,0,4.09214594928881,6.16034588762116,"B3GAT1"
"Mitochondrial trifunctional protein deficiency ORPHA:746","1/100",0.221926911560385,0.244619063633053,0,0,4.09214594928881,6.16034588762116,"SLC25A20"
"Autosomal recessive cutis laxa type 1 ORPHA:90349","1/100",0.221926911560385,0.244619063633053,0,0,4.09214594928881,6.16034588762116,"CD248"
"Propionic acidemia ORPHA:35","1/100",0.221926911560385,0.244619063633053,0,0,4.09214594928881,6.16034588762116,"GPT2"
"Autosomal recessive severe congenital neutropenia due to CXCR2 deficiency ORPHA:420699","1/101",0.223881866241205,0.244619063633053,0,0,4.05102040816327,6.06290601418737,"DEFA1"
"Congenital limbs-face contractures-hypotonia-developmental delay syndrome ORPHA:562528","1/101",0.223881866241205,0.244619063633053,0,0,4.05102040816327,6.06290601418737,"GFAP"
"Pycnodysostosis ORPHA:763","1/101",0.223881866241205,0.244619063633053,0,0,4.05102040816327,6.06290601418737,"CD248"
"14q11.2 microduplication syndrome ORPHA:261229","1/101",0.223881866241205,0.244619063633053,0,0,4.05102040816327,6.06290601418737,"GFAP"
"Isolated thyroid-stimulating hormone deficiency ORPHA:90674","1/101",0.223881866241205,0.244619063633053,0,0,4.05102040816327,6.06290601418737,"DEFA1"
"Isolated thyrotropin-releasing hormone deficiency ORPHA:238670","1/101",0.223881866241205,0.244619063633053,0,0,4.05102040816327,6.06290601418737,"BEX1"
"Jackson-Weiss syndrome ORPHA:1540","1/101",0.223881866241205,0.244619063633053,0,0,4.05102040816327,6.06290601418737,"CACHD1"
"Galactose mutarotase deficiency ORPHA:570422","1/101",0.223881866241205,0.244619063633053,0,0,4.05102040816327,6.06290601418737,"SLC25A20"
"Congenital myopathy with internal nuclei and atypical cores ORPHA:319160","1/101",0.223881866241205,0.244619063633053,0,0,4.05102040816327,6.06290601418737,"FSCN2"
"NON RARE IN EUROPE: Isolated keratoconus ORPHA:2335","1/101",0.223881866241205,0.244619063633053,0,0,4.05102040816327,6.06290601418737,"GFAP"
"Gemistocytic astrocytoma ORPHA:251604","1/101",0.223881866241205,0.244619063633053,0,0,4.05102040816327,6.06290601418737,"GRAMD4"
"2q24 microdeletion syndrome ORPHA:1617","1/101",0.223881866241205,0.244619063633053,0,0,4.05102040816327,6.06290601418737,"GFAP"
"3-hydroxy-3-methylglutaric aciduria ORPHA:20","1/101",0.223881866241205,0.244619063633053,0,0,4.05102040816327,6.06290601418737,"SLC25A20"
"Congenital stromal corneal dystrophy ORPHA:101068","1/101",0.223881866241205,0.244619063633053,0,0,4.05102040816327,6.06290601418737,"CD248"
"Autosomal recessive spastic paraplegia type 75 ORPHA:459056","1/101",0.223881866241205,0.244619063633053,0,0,4.05102040816327,6.06290601418737,"GFAP"
"Autosomal recessive spastic paraplegia type 77 ORPHA:466722","1/101",0.223881866241205,0.244619063633053,0,0,4.05102040816327,6.06290601418737,"SLC25A20"
"Ventriculomegaly-cystic kidney disease ORPHA:443988","1/101",0.223881866241205,0.244619063633053,0,0,4.05102040816327,6.06290601418737,"B3GAT1"
"3-phosphoglycerate dehydrogenase deficiency, infantile/juvenile form ORPHA:79351","1/101",0.223881866241205,0.244619063633053,0,0,4.05102040816327,6.06290601418737,"GPT2"
"Reducing body myopathy ORPHA:97239","1/101",0.223881866241205,0.244619063633053,0,0,4.05102040816327,6.06290601418737,"CACHD1"
"Coralliform cataract ORPHA:98990","1/101",0.223881866241205,0.244619063633053,0,0,4.05102040816327,6.06290601418737,"BEX1"
"Keipert syndrome ORPHA:2662","1/101",0.223881866241205,0.244619063633053,0,0,4.05102040816327,6.06290601418737,"CACHD1"
"Nance-Horan syndrome ORPHA:627","1/101",0.223881866241205,0.244619063633053,0,0,4.05102040816327,6.06290601418737,"CACHD1"
"46,XY disorder of sex development-adrenal insufficiency due to CYP11A1 deficiency ORPHA:168558","1/101",0.223881866241205,0.244619063633053,0,0,4.05102040816327,6.06290601418737,"TMEM37"
"Cortical dysplasia-focal epilepsy syndrome ORPHA:163681","1/101",0.223881866241205,0.244619063633053,0,0,4.05102040816327,6.06290601418737,"B3GAT1"
"Renin-angiotensin-aldosterone system-blocker-induced angioedema ORPHA:100057","1/101",0.223881866241205,0.244619063633053,0,0,4.05102040816327,6.06290601418737,"CD248"
"Waardenburg syndrome type 1 ORPHA:894","1/101",0.223881866241205,0.244619063633053,0,0,4.05102040816327,6.06290601418737,"CACHD1"
"Waardenburg syndrome type 3 ORPHA:896","1/101",0.223881866241205,0.244619063633053,0,0,4.05102040816327,6.06290601418737,"CACHD1"
"Craniodiaphyseal dysplasia ORPHA:1513","1/101",0.223881866241205,0.244619063633053,0,0,4.05102040816327,6.06290601418737,"KLHL4"
"Neonatal alloimmune neutropenia ORPHA:464370","1/101",0.223881866241205,0.244619063633053,0,0,4.05102040816327,6.06290601418737,"DEFA1"
"Wagner disease ORPHA:898","1/101",0.223881866241205,0.244619063633053,0,0,4.05102040816327,6.06290601418737,"CD248"
"Craniofacial-deafness-hand syndrome ORPHA:1529","1/101",0.223881866241205,0.244619063633053,0,0,4.05102040816327,6.06290601418737,"CACHD1"
"Craniosynostosis-dental anomalies ORPHA:284149","1/101",0.223881866241205,0.244619063633053,0,0,4.05102040816327,6.06290601418737,"CD248"
"Crouzon syndrome-acanthosis nigricans syndrome ORPHA:93262","1/101",0.223881866241205,0.244619063633053,0,0,4.05102040816327,6.06290601418737,"GPT2"
"LIMS2-related limb-girdle muscular dystrophy ORPHA:466801","1/101",0.223881866241205,0.244619063633053,0,0,4.05102040816327,6.06290601418737,"CD248"
"Cutis gyrata-acanthosis nigricans-craniosynostosis syndrome ORPHA:1555","1/101",0.223881866241205,0.244619063633053,0,0,4.05102040816327,6.06290601418737,"CACHD1"
"Cyclic neutropenia ORPHA:2686","1/101",0.223881866241205,0.244619063633053,0,0,4.05102040816327,6.06290601418737,"DEFA1"
"Glycogen storage disease with severe cardiomyopathy due to glycogenin deficiency ORPHA:263297","1/101",0.223881866241205,0.244619063633053,0,0,4.05102040816327,6.06290601418737,"SLC25A20"
"Neurogenic scapuloperoneal syndrome, Kaeser type ORPHA:85146","1/101",0.223881866241205,0.244619063633053,0,0,4.05102040816327,6.06290601418737,"CD248"
"Beta-thalassemia intermedia ORPHA:231222","1/101",0.223881866241205,0.244619063633053,0,0,4.05102040816327,6.06290601418737,"DEFA1"
"Beta-thalassemia major ORPHA:231214","1/101",0.223881866241205,0.244619063633053,0,0,4.05102040816327,6.06290601418737,"DEFA1"
"D-glyceric aciduria ORPHA:941","1/101",0.223881866241205,0.244619063633053,0,0,4.05102040816327,6.06290601418737,"SLC25A20"
"Beta-thalassemia-X-linked thrombocytopenia syndrome ORPHA:231393","1/101",0.223881866241205,0.244619063633053,0,0,4.05102040816327,6.06290601418737,"DEFA1"
"Greig cephalopolysyndactyly syndrome ORPHA:380","1/101",0.223881866241205,0.244619063633053,0,0,4.05102040816327,6.06290601418737,"CACHD1"
"AXIN2-related attenuated familial adenomatous polyposis ORPHA:401911","1/101",0.223881866241205,0.244619063633053,0,0,4.05102040816327,6.06290601418737,"CACHD1"
"Growth delay due to insulin-like growth factor I resistance ORPHA:73273","1/101",0.223881866241205,0.244619063633053,0,0,4.05102040816327,6.06290601418737,"CACHD1"
"X-linked dyserythropoietic anemia with abnormal platelets and neutropenia ORPHA:363727","1/101",0.223881866241205,0.244619063633053,0,0,4.05102040816327,6.06290601418737,"DEFA1"
"X-linked erythropoietic protoporphyria ORPHA:443197","1/101",0.223881866241205,0.244619063633053,0,0,4.05102040816327,6.06290601418737,"DEFA1"
"X-linked external auditory canal atresia-dilated internal auditory canal-facial dysmorphism syndrome ORPHA:500188","1/101",0.223881866241205,0.244619063633053,0,0,4.05102040816327,6.06290601418737,"CACHD1"
"Biotinidase deficiency ORPHA:79241","1/101",0.223881866241205,0.244619063633053,0,0,4.05102040816327,6.06290601418737,"SLC25A20"
"Acatalasemia ORPHA:926","1/101",0.223881866241205,0.244619063633053,0,0,4.05102040816327,6.06290601418737,"SLC25A20"
"Achondroplasia ORPHA:15","1/101",0.223881866241205,0.244619063633053,0,0,4.05102040816327,6.06290601418737,"GPT2"
"Lethal arteriopathy syndrome due to fibulin-4 deficiency ORPHA:314718","1/101",0.223881866241205,0.244619063633053,0,0,4.05102040816327,6.06290601418737,"CD248"
"X-linked intellectual disability, Najm type ORPHA:163937","1/101",0.223881866241205,0.244619063633053,0,0,4.05102040816327,6.06290601418737,"CACHD1"
"Saccharopinuria ORPHA:3124","1/101",0.223881866241205,0.244619063633053,0,0,4.05102040816327,6.06290601418737,"CACHD1"
"Delta-sarcoglycan-related  limb-girdle muscular dystrophy R6 ORPHA:219","1/101",0.223881866241205,0.244619063633053,0,0,4.05102040816327,6.06290601418737,"CD248"
"Norrie disease ORPHA:649","1/101",0.223881866241205,0.244619063633053,0,0,4.05102040816327,6.06290601418737,"GFAP"
"Obesity due to CEP19 deficiency ORPHA:397615","1/101",0.223881866241205,0.244619063633053,0,0,4.05102040816327,6.06290601418737,"CBX3P2"
"Dermatosparaxis Ehlers-Danlos syndrome ORPHA:1901","1/101",0.223881866241205,0.244619063633053,0,0,4.05102040816327,6.06290601418737,"CD248"
"Desminopathy ORPHA:98909","1/101",0.223881866241205,0.244619063633053,0,0,4.05102040816327,6.06290601418737,"CD248"
"Acromesomelic dysplasia, Maroteaux type ORPHA:40","1/101",0.223881866241205,0.244619063633053,0,0,4.05102040816327,6.06290601418737,"CD248"
"Brachydactyly type B2 ORPHA:140908","1/101",0.223881866241205,0.244619063633053,0,0,4.05102040816327,6.06290601418737,"GIMAP3P"
"Schilbach-Rott syndrome ORPHA:2353","1/101",0.223881866241205,0.244619063633053,0,0,4.05102040816327,6.06290601418737,"B3GAT1"
"Desmosterolosis ORPHA:35107","1/101",0.223881866241205,0.244619063633053,0,0,4.05102040816327,6.06290601418737,"GPT2"
"Acroosteolysis-keloid-like lesions-premature aging syndrome ORPHA:363665","1/101",0.223881866241205,0.244619063633053,0,0,4.05102040816327,6.06290601418737,"CD248"
"Hemoglobin C disease ORPHA:2132","1/101",0.223881866241205,0.244619063633053,0,0,4.05102040816327,6.06290601418737,"DEFA1"
"Leukoencephalopathy-dystonia-motor neuropathy syndrome ORPHA:163684","1/101",0.223881866241205,0.244619063633053,0,0,4.05102040816327,6.06290601418737,"SLC25A20"
"Hemoglobin C-beta-thalassemia syndrome ORPHA:231242","1/101",0.223881866241205,0.244619063633053,0,0,4.05102040816327,6.06290601418737,"DEFA1"
"Hemoglobin D disease ORPHA:90039","1/101",0.223881866241205,0.244619063633053,0,0,4.05102040816327,6.06290601418737,"DEFA1"
"Hemoglobin E disease ORPHA:2133","1/101",0.223881866241205,0.244619063633053,0,0,4.05102040816327,6.06290601418737,"DEFA1"
"Leukonychia totalis ORPHA:2387","1/101",0.223881866241205,0.244619063633053,0,0,4.05102040816327,6.06290601418737,"CD248"
"Hemoglobin E-beta-thalassemia syndrome ORPHA:231249","1/101",0.223881866241205,0.244619063633053,0,0,4.05102040816327,6.06290601418737,"DEFA1"
"X-linked myopathy with postural muscle atrophy ORPHA:178461","1/101",0.223881866241205,0.244619063633053,0,0,4.05102040816327,6.06290601418737,"CACHD1"
"Sea-blue histiocytosis ORPHA:158029","1/101",0.223881866241205,0.244619063633053,0,0,4.05102040816327,6.06290601418737,"TMEM37"
"Hemoglobinopathy Toms River ORPHA:280615","1/101",0.223881866241205,0.244619063633053,0,0,4.05102040816327,6.06290601418737,"DEFA1"
"Brain dopamine-serotonin vesicular transport disease ORPHA:352649","1/101",0.223881866241205,0.244619063633053,0,0,4.05102040816327,6.06290601418737,"DEFA1"
"Acute megakaryoblastic leukemia in Down syndrome ORPHA:99887","1/101",0.223881866241205,0.244619063633053,0,0,4.05102040816327,6.06290601418737,"DEFA1"
"X-linked scapuloperoneal muscular dystrophy ORPHA:431272","1/101",0.223881866241205,0.244619063633053,0,0,4.05102040816327,6.06290601418737,"CACHD1"
"X-linked sideroblastic anemia ORPHA:75563","1/101",0.223881866241205,0.244619063633053,0,0,4.05102040816327,6.06290601418737,"DEFA1"
"Lipoprotein glomerulopathy ORPHA:329481","1/101",0.223881866241205,0.244619063633053,0,0,4.05102040816327,6.06290601418737,"TMEM37"
"Odontohypophosphatasia ORPHA:247685","1/101",0.223881866241205,0.244619063633053,0,0,4.05102040816327,6.06290601418737,"DEFA1"
"Hereditary angioedema type 1 ORPHA:100050","1/101",0.223881866241205,0.244619063633053,0,0,4.05102040816327,6.06290601418737,"CD248"
"Lissencephaly due to TUBA1A mutation ORPHA:171680","1/101",0.223881866241205,0.244619063633053,0,0,4.05102040816327,6.06290601418737,"BEX1"
"Hereditary angioedema type 2 ORPHA:100051","1/101",0.223881866241205,0.244619063633053,0,0,4.05102040816327,6.06290601418737,"CD248"
"Oligoastrocytoma ORPHA:251656","1/101",0.223881866241205,0.244619063633053,0,0,4.05102040816327,6.06290601418737,"GRAMD4"
"Severe achondroplasia-developmental delay-acanthosis nigricans syndrome ORPHA:85165","1/101",0.223881866241205,0.244619063633053,0,0,4.05102040816327,6.06290601418737,"GPT2"
"Acute neonatal citrullinemia type I ORPHA:247546","1/101",0.223881866241205,0.244619063633053,0,0,4.05102040816327,6.06290601418737,"GPT2"
"C1 inhibitor deficiency ORPHA:459353","1/101",0.223881866241205,0.244619063633053,0,0,4.05102040816327,6.06290601418737,"CD248"
"Oligodontia-cancer predisposition syndrome ORPHA:300576","1/101",0.223881866241205,0.244619063633053,0,0,4.05102040816327,6.06290601418737,"CACHD1"
"Hereditary continuous muscle fiber activity ORPHA:972","1/101",0.223881866241205,0.244619063633053,0,0,4.05102040816327,6.06290601418737,"GFAP"
"Hereditary cryohydrocytosis with normal stomatin ORPHA:398088","1/101",0.223881866241205,0.244619063633053,0,0,4.05102040816327,6.06290601418737,"DEFA1"
"Hereditary folate malabsorption ORPHA:90045","1/101",0.223881866241205,0.244619063633053,0,0,4.05102040816327,6.06290601418737,"TMEM37"
"Adult hypophosphatasia ORPHA:247676","1/101",0.223881866241205,0.244619063633053,0,0,4.05102040816327,6.06290601418737,"DEFA1"
"Distal renal tubular acidosis with anemia ORPHA:93610","1/101",0.223881866241205,0.244619063633053,0,0,4.05102040816327,6.06290601418737,"DEFA1"
"CIDEC-related familial partial lipodystrophy ORPHA:435651","1/101",0.223881866241205,0.244619063633053,0,0,4.05102040816327,6.06290601418737,"TMEM37"
"Dominant beta-thalassemia ORPHA:231226","1/101",0.223881866241205,0.244619063633053,0,0,4.05102040816327,6.06290601418737,"DEFA1"
"Hereditary hypophosphatemic rickets with hypercalciuria ORPHA:157215","1/101",0.223881866241205,0.244619063633053,0,0,4.05102040816327,6.06290601418737,"FSCN2"
"Adult-onset citrullinemia type I ORPHA:247573","1/101",0.223881866241205,0.244619063633053,0,0,4.05102040816327,6.06290601418737,"GPT2"
"Dopamine beta-hydroxylase deficiency ORPHA:230","1/101",0.223881866241205,0.244619063633053,0,0,4.05102040816327,6.06290601418737,"CD248"
"Osteogenesis imperfecta type 5 ORPHA:216828","1/101",0.223881866241205,0.244619063633053,0,0,4.05102040816327,6.06290601418737,"ODF3"
"Dysbetalipoproteinemia ORPHA:412","1/101",0.223881866241205,0.244619063633053,0,0,4.05102040816327,6.06290601418737,"TMEM37"
"Dyschromatosis universalis hereditaria ORPHA:241","1/101",0.223881866241205,0.244619063633053,0,0,4.05102040816327,6.06290601418737,"GPT2"
"Alexander disease type I ORPHA:363717","1/101",0.223881866241205,0.244619063633053,0,0,4.05102040816327,6.06290601418737,"GFAP"
"Alexander disease type II ORPHA:363722","1/101",0.223881866241205,0.244619063633053,0,0,4.05102040816327,6.06290601418737,"GFAP"
"Short chain acyl-CoA dehydrogenase deficiency ORPHA:26792","1/101",0.223881866241205,0.244619063633053,0,0,4.05102040816327,6.06290601418737,"SLC25A20"
"PDE4D haploinsufficiency syndrome ORPHA:439822","1/101",0.223881866241205,0.244619063633053,0,0,4.05102040816327,6.06290601418737,"LRRN3"
"Hereditary sensorimotor neuropathy with hyperelastic skin ORPHA:280598","1/101",0.223881866241205,0.244619063633053,0,0,4.05102040816327,6.06290601418737,"CD248"
"EMILIN-1-related connective tissue disease ORPHA:485418","1/101",0.223881866241205,0.244619063633053,0,0,4.05102040816327,6.06290601418737,"CD248"
"Short rib-polydactyly syndrome, Saldino-Noonan type ORPHA:93270","1/101",0.223881866241205,0.244619063633053,0,0,4.05102040816327,6.06290601418737,"CACHD1"
"Camptodactyly-tall stature-scoliosis-hearing loss syndrome ORPHA:85164","1/101",0.223881866241205,0.244619063633053,0,0,4.05102040816327,6.06290601418737,"GPT2"
"Alpha-sarcoglycan-related  limb-girdle muscular dystrophy R3 ORPHA:62","1/101",0.223881866241205,0.244619063633053,0,0,4.05102040816327,6.06290601418737,"CD248"
"Carcinoid syndrome ORPHA:100093","1/101",0.223881866241205,0.244619063633053,0,0,4.05102040816327,6.06290601418737,"SLC25A20"
"PMP2-related Charcot-Marie-Tooth disease type 1 ORPHA:476394","1/101",0.223881866241205,0.244619063633053,0,0,4.05102040816327,6.06290601418737,"GFAP"
"Cardiac-valvular Ehlers-Danlos syndrome ORPHA:230851","1/101",0.223881866241205,0.244619063633053,0,0,4.05102040816327,6.06290601418737,"CD248"
"Sickle cell anemia ORPHA:232","1/101",0.223881866241205,0.244619063633053,0,0,4.05102040816327,6.06290601418737,"DEFA1"
"Sickle cell-beta-thalassemia disease syndrome ORPHA:251359","1/101",0.223881866241205,0.244619063633053,0,0,4.05102040816327,6.06290601418737,"DEFA1"
"Carnitine-acylcarnitine translocase deficiency ORPHA:159","1/101",0.223881866241205,0.244619063633053,0,0,4.05102040816327,6.06290601418737,"SLC25A20"
"Sickle cell-hemoglobin C disease syndrome ORPHA:251365","1/101",0.223881866241205,0.244619063633053,0,0,4.05102040816327,6.06290601418737,"DEFA1"
"Sickle cell-hemoglobin D disease syndrome ORPHA:251370","1/101",0.223881866241205,0.244619063633053,0,0,4.05102040816327,6.06290601418737,"DEFA1"
"Anaplastic astrocytoma ORPHA:251589","1/101",0.223881866241205,0.244619063633053,0,0,4.05102040816327,6.06290601418737,"GRAMD4"
"Sickle cell-hemoglobin E disease syndrome ORPHA:251375","1/101",0.223881866241205,0.244619063633053,0,0,4.05102040816327,6.06290601418737,"DEFA1"
"Anaplastic oligoastrocytoma ORPHA:251663","1/101",0.223881866241205,0.244619063633053,0,0,4.05102040816327,6.06290601418737,"GRAMD4"
"Pallister-Hall syndrome ORPHA:672","1/101",0.223881866241205,0.244619063633053,0,0,4.05102040816327,6.06290601418737,"CACHD1"
"Histidinemia ORPHA:2157","1/101",0.223881866241205,0.244619063633053,0,0,4.05102040816327,6.06290601418737,"DEFA1"
"Holt-Oram syndrome ORPHA:392","1/101",0.223881866241205,0.244619063633053,0,0,4.05102040816327,6.06290601418737,"CD248"
"Sjogren-Larsson syndrome ORPHA:816","1/101",0.223881866241205,0.244619063633053,0,0,4.05102040816327,6.06290601418737,"TMEM37"
"Skeletal overgrowth-craniofacial dysmorphism-hyperelastic skin-white matter lesions syndrome ORPHA:477831","1/101",0.223881866241205,0.244619063633053,0,0,4.05102040816327,6.06290601418737,"CD248"
"Apert syndrome ORPHA:87","1/101",0.223881866241205,0.244619063633053,0,0,4.05102040816327,6.06290601418737,"CACHD1"
"Hyaluronidase deficiency ORPHA:67041","1/101",0.223881866241205,0.244619063633053,0,0,4.05102040816327,6.06290601418737,"TMEM37"
"Southeast Asian ovalocytosis ORPHA:98868","1/101",0.223881866241205,0.244619063633053,0,0,4.05102040816327,6.06290601418737,"DEFA1"
"Argininemia ORPHA:90","1/101",0.223881866241205,0.244619063633053,0,0,4.05102040816327,6.06290601418737,"DEFA1"
"Epileptic encephalopathy with global cerebral demyelination ORPHA:353217","1/101",0.223881866241205,0.244619063633053,0,0,4.05102040816327,6.06290601418737,"KCNQ5"
"Episodic ataxia type 1 ORPHA:37612","1/101",0.223881866241205,0.244619063633053,0,0,4.05102040816327,6.06290601418737,"GFAP"
"Episodic ataxia type 6 ORPHA:209967","1/101",0.223881866241205,0.244619063633053,0,0,4.05102040816327,6.06290601418737,"GFAP"
"Spastic tetraplegia-thin corpus callosum-progressive postnatal microcephaly syndrome ORPHA:447997","1/101",0.223881866241205,0.244619063633053,0,0,4.05102040816327,6.06290601418737,"KCNQ5"
"Spectrin-associated autosomal recessive cerebellar ataxia ORPHA:352403","1/101",0.223881866241205,0.244619063633053,0,0,4.05102040816327,6.06290601418737,"GPT2"
"Hyperekplexia-epilepsy syndrome ORPHA:163985","1/101",0.223881866241205,0.244619063633053,0,0,4.05102040816327,6.06290601418737,"B3GAT1"
"Hyperinsulinism due to glucokinase deficiency ORPHA:79299","1/101",0.223881866241205,0.244619063633053,0,0,4.05102040816327,6.06290601418737,"BEX1"
"Charcot-Marie-Tooth disease type 2R ORPHA:397968","1/101",0.223881866241205,0.244619063633053,0,0,4.05102040816327,6.06290601418737,"CACHD1"
"Charcot-Marie-Tooth disease type 4B1 ORPHA:99955","1/101",0.223881866241205,0.244619063633053,0,0,4.05102040816327,6.06290601418737,"POLR3G"
"Hyperlysinemia ORPHA:2203","1/101",0.223881866241205,0.244619063633053,0,0,4.05102040816327,6.06290601418737,"CACHD1"
"Perinatal lethal hypophosphatasia ORPHA:247623","1/101",0.223881866241205,0.244619063633053,0,0,4.05102040816327,6.06290601418737,"DEFA1"
"Hyperphenylalaninemia due to DNAJC12 deficiency ORPHA:508523","1/101",0.223881866241205,0.244619063633053,0,0,4.05102040816327,6.06290601418737,"GPT2"
"FGFR2-related bent bone dysplasia ORPHA:313855","1/101",0.223881866241205,0.244619063633053,0,0,4.05102040816327,6.06290601418737,"CACHD1"
"Hyperprolinemia type 2 ORPHA:79101","1/101",0.223881866241205,0.244619063633053,0,0,4.05102040816327,6.06290601418737,"GPT2"
"Peripheral demyelinating neuropathy-central dysmyelinating leukodystrophy-Waardenburg syndrome-Hirschsprung disease ORPHA:163746","1/101",0.223881866241205,0.244619063633053,0,0,4.05102040816327,6.06290601418737,"GFAP"
"Spinocerebellar ataxia type 34 ORPHA:1955","1/101",0.223881866241205,0.244619063633053,0,0,4.05102040816327,6.06290601418737,"CACHD1"
"FOXG1 syndrome ORPHA:561854","1/101",0.223881866241205,0.244619063633053,0,0,4.05102040816327,6.06290601418737,"GFAP"
"FOXG1 syndrome due to 14q12 microdeletion ORPHA:261144","1/101",0.223881866241205,0.244619063633053,0,0,4.05102040816327,6.06290601418737,"GFAP"
"Metaphyseal chondromatosis with D-2-hydroxyglutaric aciduria ORPHA:99646","1/101",0.223881866241205,0.244619063633053,0,0,4.05102040816327,6.06290601418737,"TMEM37"
"Childhood-onset hypophosphatasia ORPHA:247667","1/101",0.223881866241205,0.244619063633053,0,0,4.05102040816327,6.06290601418737,"DEFA1"
"Hypochondroplasia ORPHA:429","1/101",0.223881866241205,0.244619063633053,0,0,4.05102040816327,6.06290601418737,"GPT2"
"Spinocerebellar ataxia type 5 ORPHA:98766","1/101",0.223881866241205,0.244619063633053,0,0,4.05102040816327,6.06290601418737,"GPT2"
"Pfeiffer syndrome type 2 ORPHA:93259","1/101",0.223881866241205,0.244619063633053,0,0,4.05102040816327,6.06290601418737,"CACHD1"
"Pfeiffer syndrome type 3 ORPHA:93260","1/101",0.223881866241205,0.244619063633053,0,0,4.05102040816327,6.06290601418737,"CACHD1"
"Chondromyxoid fibroma ORPHA:404507","1/101",0.223881866241205,0.244619063633053,0,0,4.05102040816327,6.06290601418737,"GFAP"
"Phocomelia, Schinzel type ORPHA:2879","1/101",0.223881866241205,0.244619063633053,0,0,4.05102040816327,6.06290601418737,"GIMAP3P"
"Hypomyelination-congenital cataract syndrome ORPHA:85163","1/101",0.223881866241205,0.244619063633053,0,0,4.05102040816327,6.06290601418737,"ADAMTS6"
"Pigmented paravenous retinochoroidal atrophy ORPHA:251295","1/101",0.223881866241205,0.244619063633053,0,0,4.05102040816327,6.06290601418737,"GFAP"
"Chronic myeloproliferative disease, unclassifiable ORPHA:86830","1/101",0.223881866241205,0.244619063633053,0,0,4.05102040816327,6.06290601418737,"CD248"
"Chronic respiratory distress with surfactant metabolism deficiency ORPHA:217566","1/101",0.223881866241205,0.244619063633053,0,0,4.05102040816327,6.06290601418737,"GFAP"
"Microcornea-myopic chorioretinal atrophy-telecanthus syndrome ORPHA:369970","1/101",0.223881866241205,0.244619063633053,0,0,4.05102040816327,6.06290601418737,"KLHL4"
"Hypotrichosis-lymphedema-telangiectasia-renal defect syndrome ORPHA:69735","1/101",0.223881866241205,0.244619063633053,0,0,4.05102040816327,6.06290601418737,"TMEM37"
"Polyglucosan body myopathy type 2 ORPHA:456369","1/101",0.223881866241205,0.244619063633053,0,0,4.05102040816327,6.06290601418737,"SLC25A20"
"Classic homocystinuria ORPHA:394","1/101",0.223881866241205,0.244619063633053,0,0,4.05102040816327,6.06290601418737,"GPT2"
"Polysyndactyly ORPHA:93338","1/101",0.223881866241205,0.244619063633053,0,0,4.05102040816327,6.06290601418737,"CACHD1"
"Stapes ankylosis with broad thumbs and toes ORPHA:140917","1/101",0.223881866241205,0.244619063633053,0,0,4.05102040816327,6.06290601418737,"GIMAP3P"
"Classic progressive supranuclear palsy syndrome ORPHA:240071","1/101",0.223881866241205,0.244619063633053,0,0,4.05102040816327,6.06290601418737,"GFAP"
"Classical-like Ehlers-Danlos syndrome type 1 ORPHA:230839","1/101",0.223881866241205,0.244619063633053,0,0,4.05102040816327,6.06290601418737,"CD248"
"Classical-like Ehlers-Danlos syndrome type 2 ORPHA:536532","1/101",0.223881866241205,0.244619063633053,0,0,4.05102040816327,6.06290601418737,"CD248"
"Autosomal dominant distal renal tubular acidosis ORPHA:93608","1/101",0.223881866241205,0.244619063633053,0,0,4.05102040816327,6.06290601418737,"DEFA1"
"Immune dysregulation-polyendocrinopathy-enteropathy-X-linked syndrome ORPHA:37042","1/101",0.223881866241205,0.244619063633053,0,0,4.05102040816327,6.06290601418737,"ZNF683"
"Autosomal dominant focal dystonia, DYT25 type ORPHA:329466","1/101",0.223881866241205,0.244619063633053,0,0,4.05102040816327,6.06290601418737,"B3GAT1"
"Coats disease ORPHA:190","1/101",0.223881866241205,0.244619063633053,0,0,4.05102040816327,6.06290601418737,"GFAP"
"Postaxial polydactyly-anterior pituitary anomalies-facial dysmorphism syndrome ORPHA:420584","1/101",0.223881866241205,0.244619063633053,0,0,4.05102040816327,6.06290601418737,"CACHD1"
"Mitochondrial pyruvate carrier deficiency ORPHA:447784","1/101",0.223881866241205,0.244619063633053,0,0,4.05102040816327,6.06290601418737,"SLC25A20"
"Supravalvular aortic stenosis ORPHA:3193","1/101",0.223881866241205,0.244619063633053,0,0,4.05102040816327,6.06290601418737,"CD248"
"Immunodeficiency with factor I anomaly ORPHA:200418","1/101",0.223881866241205,0.244619063633053,0,0,4.05102040816327,6.06290601418737,"TMEM37"
"Postnatal microcephaly-infantile hypotonia-spastic diplegia-dysarthria-intellectual disability syndrome ORPHA:477673","1/101",0.223881866241205,0.244619063633053,0,0,4.05102040816327,6.06290601418737,"GPT2"
"Infant acute respiratory distress syndrome ORPHA:70587","1/101",0.223881866241205,0.244619063633053,0,0,4.05102040816327,6.06290601418737,"GFAP"
"Familial isolated trichomegaly ORPHA:411788","1/101",0.223881866241205,0.244619063633053,0,0,4.05102040816327,6.06290601418737,"ADAMTS6"
"Monoamine oxidase A deficiency ORPHA:3057","1/101",0.223881866241205,0.244619063633053,0,0,4.05102040816327,6.06290601418737,"TMEM37"
"Colobomatous optic disc-macular atrophy-chorioretinopathy syndrome ORPHA:435930","1/101",0.223881866241205,0.244619063633053,0,0,4.05102040816327,6.06290601418737,"SNTG2"
"Infantile hypophosphatasia ORPHA:247651","1/101",0.223881866241205,0.244619063633053,0,0,4.05102040816327,6.06290601418737,"DEFA1"
"Monosomy 9q22.3 ORPHA:77301","1/101",0.223881866241205,0.244619063633053,0,0,4.05102040816327,6.06290601418737,"B3GAT1"
"Familial mitral valve prolapse ORPHA:741","1/101",0.223881866241205,0.244619063633053,0,0,4.05102040816327,6.06290601418737,"CD248"
"Prenatal benign hypophosphatasia ORPHA:247638","1/101",0.223881866241205,0.244619063633053,0,0,4.05102040816327,6.06290601418737,"DEFA1"
"Primary dystonia, DYT27 type ORPHA:464440","1/101",0.223881866241205,0.244619063633053,0,0,4.05102040816327,6.06290601418737,"CD248"
"Mucopolysaccharidosis type 2, attenuated form ORPHA:217093","1/101",0.223881866241205,0.244619063633053,0,0,4.05102040816327,6.06290601418737,"SLC4A10"
"Mucopolysaccharidosis type 2, severe form ORPHA:217085","1/101",0.223881866241205,0.244619063633053,0,0,4.05102040816327,6.06290601418737,"SLC4A10"
"Autosomal dominant primary microcephaly ORPHA:2514","1/101",0.223881866241205,0.244619063633053,0,0,4.05102040816327,6.06290601418737,"GFAP"
"Muenke syndrome ORPHA:53271","1/101",0.223881866241205,0.244619063633053,0,0,4.05102040816327,6.06290601418737,"GPT2"
"Primary hypomagnesemia with secondary hypocalcemia ORPHA:30924","1/101",0.223881866241205,0.244619063633053,0,0,4.05102040816327,6.06290601418737,"DEFA1"
"Inherited isolated adrenal insufficiency due to partial CYP11A1 deficiency ORPHA:289548","1/101",0.223881866241205,0.244619063633053,0,0,4.05102040816327,6.06290601418737,"TMEM37"
"Combined oxidative phosphorylation defect type 14 ORPHA:319519","1/101",0.223881866241205,0.244619063633053,0,0,4.05102040816327,6.06290601418737,"SLC25A20"
"Familial pseudohyperkalemia ORPHA:90044","1/101",0.223881866241205,0.244619063633053,0,0,4.05102040816327,6.06290601418737,"GPT2"
"Multifocal pattern dystrophy simulating fundus flavimaculatus ORPHA:99003","1/101",0.223881866241205,0.244619063633053,0,0,4.05102040816327,6.06290601418737,"CD248"
"Familial scaphocephaly syndrome, McGillivray type ORPHA:168624","1/101",0.223881866241205,0.244619063633053,0,0,4.05102040816327,6.06290601418737,"CACHD1"
"Intellectual disability-developmental delay-contractures syndrome ORPHA:3454","1/101",0.223881866241205,0.244619063633053,0,0,4.05102040816327,6.06290601418737,"BEX1"
"Multiple epiphyseal dysplasia type 1 ORPHA:93308","1/101",0.223881866241205,0.244619063633053,0,0,4.05102040816327,6.06290601418737,"CD248"
"Tall stature-scoliosis-macrodactyly of the great toes syndrome ORPHA:329191","1/101",0.223881866241205,0.244619063633053,0,0,4.05102040816327,6.06290601418737,"CD248"
"Familial visceral myopathy ORPHA:2604","1/101",0.223881866241205,0.244619063633053,0,0,4.05102040816327,6.06290601418737,"CD248"
"Tarsal-carpal coalition syndrome ORPHA:1412","1/101",0.223881866241205,0.244619063633053,0,0,4.05102040816327,6.06290601418737,"GIMAP3P"
"Tatton-Brown-Rahman syndrome ORPHA:404443","1/101",0.223881866241205,0.244619063633053,0,0,4.05102040816327,6.06290601418737,"B3GAT1"
"Fatal post-viral neurodegenerative disorder ORPHA:391343","1/101",0.223881866241205,0.244619063633053,0,0,4.05102040816327,6.06290601418737,"ZNF683"
"Progressive myoclonic epilepsy type 3 ORPHA:263516","1/101",0.223881866241205,0.244619063633053,0,0,4.05102040816327,6.06290601418737,"LRRN3"
"Autosomal recessive ataxia, Beauce type ORPHA:88644","1/101",0.223881866241205,0.244619063633053,0,0,4.05102040816327,6.06290601418737,"LRRN3"
"Congenital adrenal hyperplasia due to 11-beta-hydroxylase deficiency ORPHA:90795","1/101",0.223881866241205,0.244619063633053,0,0,4.05102040816327,6.06290601418737,"ZNF683"
"Interstitial lung disease due to SP-C deficiency ORPHA:440392","1/101",0.223881866241205,0.244619063633053,0,0,4.05102040816327,6.06290601418737,"GFAP"
"Multisystemic smooth muscle dysfunction syndrome ORPHA:404463","1/101",0.223881866241205,0.244619063633053,0,0,4.05102040816327,6.06290601418737,"CD248"
"Progressive retinal dystrophy due to retinol transport defect ORPHA:352718","1/101",0.223881866241205,0.244619063633053,0,0,4.05102040816327,6.06290601418737,"TMEM37"
"Thanatophoric dysplasia type 1 ORPHA:1860","1/101",0.223881866241205,0.244619063633053,0,0,4.05102040816327,6.06290601418737,"GPT2"
"Thanatophoric dysplasia type 2 ORPHA:93274","1/101",0.223881866241205,0.244619063633053,0,0,4.05102040816327,6.06290601418737,"GPT2"
"Fibrillary astrocytoma ORPHA:251601","1/101",0.223881866241205,0.244619063633053,0,0,4.05102040816327,6.06290601418737,"GRAMD4"
"Progressive supranuclear palsy-corticobasal syndrome ORPHA:240103","1/101",0.223881866241205,0.244619063633053,0,0,4.05102040816327,6.06290601418737,"GFAP"
"Progressive supranuclear palsy-parkinsonism syndrome ORPHA:240085","1/101",0.223881866241205,0.244619063633053,0,0,4.05102040816327,6.06290601418737,"GFAP"
"Progressive supranuclear palsy-progressive non-fluent aphasia syndrome ORPHA:240112","1/101",0.223881866241205,0.244619063633053,0,0,4.05102040816327,6.06290601418737,"GFAP"
"Progressive supranuclear palsy-pure akinesia with gait freezing syndrome ORPHA:240094","1/101",0.223881866241205,0.244619063633053,0,0,4.05102040816327,6.06290601418737,"GFAP"
"Autosomal recessive congenital cerebellar ataxia due to MGLUR1 deficiency ORPHA:324262","1/101",0.223881866241205,0.244619063633053,0,0,4.05102040816327,6.06290601418737,"GFAP"
"Myeloid/lymphoid neoplasm associated with PDGFRB rearrangement ORPHA:168950","1/101",0.223881866241205,0.244619063633053,0,0,4.05102040816327,6.06290601418737,"CD248"
"Isolated autosomal dominant hypomagnesemia, Glaudemans type ORPHA:199326","1/101",0.223881866241205,0.244619063633053,0,0,4.05102040816327,6.06290601418737,"GFAP"
"Myeloperoxidase deficiency ORPHA:2587","1/101",0.223881866241205,0.244619063633053,0,0,4.05102040816327,6.06290601418737,"DEFA1"
"Thrombocytopenia with congenital dyserythropoietic anemia ORPHA:67044","1/101",0.223881866241205,0.244619063633053,0,0,4.05102040816327,6.06290601418737,"DEFA1"
"Protoplasmic astrocytoma ORPHA:251598","1/101",0.223881866241205,0.244619063633053,0,0,4.05102040816327,6.06290601418737,"GRAMD4"
"Congenital cornea plana ORPHA:53691","1/101",0.223881866241205,0.244619063633053,0,0,4.05102040816327,6.06290601418737,"CD248"
"Myopathic intestinal pseudoobstruction ORPHA:104077","1/101",0.223881866241205,0.244619063633053,0,0,4.05102040816327,6.06290601418737,"CD248"
"Myosclerosis ORPHA:289380","1/101",0.223881866241205,0.244619063633053,0,0,4.05102040816327,6.06290601418737,"CD248"
"Tibial hemimelia ORPHA:93322","1/101",0.223881866241205,0.244619063633053,0,0,4.05102040816327,6.06290601418737,"CACHD1"
"Timothy syndrome ORPHA:65283","1/101",0.223881866241205,0.244619063633053,0,0,4.05102040816327,6.06290601418737,"CD248"
"Congenital dyserythropoietic anemia type IV ORPHA:293825","1/101",0.223881866241205,0.244619063633053,0,0,4.05102040816327,6.06290601418737,"DEFA1"
"Fraser syndrome ORPHA:2052","1/101",0.223881866241205,0.244619063633053,0,0,4.05102040816327,6.06290601418737,"CACHD1"
"Pseudoachondroplasia ORPHA:750","1/101",0.223881866241205,0.244619063633053,0,0,4.05102040816327,6.06290601418737,"CD248"
"Congenital factor X deficiency ORPHA:328","1/101",0.223881866241205,0.244619063633053,0,0,4.05102040816327,6.06290601418737,"TMEM37"
"NKX6-2-related autosomal recessive hypomyelinating leukodystrophy ORPHA:527497","1/101",0.223881866241205,0.244619063633053,0,0,4.05102040816327,6.06290601418737,"GFAP"
"Transcobalamin deficiency ORPHA:859","1/101",0.223881866241205,0.244619063633053,0,0,4.05102040816327,6.06290601418737,"TMEM37"
"Transient infantile hypertriglyceridemia and hepatosteatosis ORPHA:300293","1/101",0.223881866241205,0.244619063633053,0,0,4.05102040816327,6.06290601418737,"TMEM37"
"Transient myeloproliferative syndrome ORPHA:420611","1/101",0.223881866241205,0.244619063633053,0,0,4.05102040816327,6.06290601418737,"DEFA1"
"Autosomal recessive myogenic arthrogryposis multiplex congenita ORPHA:319332","1/101",0.223881866241205,0.244619063633053,0,0,4.05102040816327,6.06290601418737,"LRRN3"
"Congenital ichthyosis-intellectual disability-spastic quadriplegia syndrome ORPHA:352333","1/101",0.223881866241205,0.244619063633053,0,0,4.05102040816327,6.06290601418737,"CACHD1"
"NON RARE IN EUROPE: Berger disease ORPHA:34145","1/101",0.223881866241205,0.244619063633053,0,0,4.05102040816327,6.06290601418737,"CD248"
"Fuhrmann syndrome ORPHA:2854","1/101",0.223881866241205,0.244619063633053,0,0,4.05102040816327,6.06290601418737,"GIMAP3P"
"Truncus arteriosus ORPHA:3384","1/102",0.225832006978328,0.244619063633053,0,0,4.01070923418872,5.96779050603106,"CD248"
"Congenital sodium diarrhea ORPHA:103908","1/102",0.225832006978328,0.244619063633053,0,0,4.01070923418872,5.96779050603106,"GRAMD4"
"Continuous spikes and waves during sleep ORPHA:725","1/102",0.225832006978328,0.244619063633053,0,0,4.01070923418872,5.96779050603106,"GFAP"
"Glanzmann thrombasthenia ORPHA:849","1/102",0.225832006978328,0.244619063633053,0,0,4.01070923418872,5.96779050603106,"DEFA1"
"Renal hypoplasia, bilateral ORPHA:97362","1/102",0.225832006978328,0.244619063633053,0,0,4.01070923418872,5.96779050603106,"CACHD1"
"Glycogen storage disease due to muscle phosphorylase kinase deficiency ORPHA:715","1/102",0.225832006978328,0.244619063633053,0,0,4.01070923418872,5.96779050603106,"GPT2"
"Bernard-Soulier syndrome ORPHA:274","1/102",0.225832006978328,0.244619063633053,0,0,4.01070923418872,5.96779050603106,"DEFA1"
"D-2-hydroxyglutaric aciduria ORPHA:79315","1/102",0.225832006978328,0.244619063633053,0,0,4.01070923418872,5.96779050603106,"GRAMD4"
"Hereditary diffuse leukoencephalopathy with axonal spheroids and pigmented glia ORPHA:313808","1/102",0.225832006978328,0.244619063633053,0,0,4.01070923418872,5.96779050603106,"GRAMD4"
"Hereditary methemoglobinemia ORPHA:621","1/102",0.225832006978328,0.244619063633053,0,0,4.01070923418872,5.96779050603106,"TMEM37"
"Agnathia-holoprosencephaly-situs inversus syndrome ORPHA:990","1/102",0.225832006978328,0.244619063633053,0,0,4.01070923418872,5.96779050603106,"CACHD1"
"Otofaciocervical syndrome ORPHA:2792","1/102",0.225832006978328,0.244619063633053,0,0,4.01070923418872,5.96779050603106,"MPPED2"
"Hereditary persistence of fetal hemoglobin-sickle cell disease syndrome ORPHA:251380","1/102",0.225832006978328,0.244619063633053,0,0,4.01070923418872,5.96779050603106,"DEFA1"
"Hereditary sensory and autonomic neuropathy type 5 ORPHA:64752","1/102",0.225832006978328,0.244619063633053,0,0,4.01070923418872,5.96779050603106,"CD248"
"Maffucci syndrome ORPHA:163634","1/102",0.225832006978328,0.244619063633053,0,0,4.01070923418872,5.96779050603106,"TMEM37"
"Pachydermoperiostosis ORPHA:2796","1/102",0.225832006978328,0.244619063633053,0,0,4.01070923418872,5.96779050603106,"TMEM37"
"Palmoplantar keratoderma-hereditary motor and sensory neuropathy syndrome ORPHA:538574","1/102",0.225832006978328,0.244619063633053,0,0,4.01070923418872,5.96779050603106,"FGFBP2"
"Aniridia-cerebellar ataxia-intellectual disability syndrome ORPHA:1065","1/102",0.225832006978328,0.244619063633053,0,0,4.01070923418872,5.96779050603106,"GFAP"
"Encephalocraniocutaneous lipomatosis ORPHA:2396","1/102",0.225832006978328,0.244619063633053,0,0,4.01070923418872,5.96779050603106,"CACHD1"
"Antley-Bixler syndrome ORPHA:83","1/102",0.225832006978328,0.244619063633053,0,0,4.01070923418872,5.96779050603106,"TMEM37"
"Cerebrofacioarticular syndrome ORPHA:314679","1/102",0.225832006978328,0.244619063633053,0,0,4.01070923418872,5.96779050603106,"CACHD1"
"Parkinsonian-pyramidal syndrome ORPHA:171695","1/102",0.225832006978328,0.244619063633053,0,0,4.01070923418872,5.96779050603106,"DEFA1"
"Paternal uniparental disomy of chromosome 6 ORPHA:96191","1/102",0.225832006978328,0.244619063633053,0,0,4.01070923418872,5.96779050603106,"CD248"
"FRAXE intellectual disability ORPHA:100973","1/102",0.225832006978328,0.244619063633053,0,0,4.01070923418872,5.96779050603106,"B3GAT1"
"Pfeiffer syndrome type 1 ORPHA:93258","1/102",0.225832006978328,0.244619063633053,0,0,4.01070923418872,5.96779050603106,"CACHD1"
"Piebaldism ORPHA:2884","1/102",0.225832006978328,0.244619063633053,0,0,4.01070923418872,5.96779050603106,"CACHD1"
"Hypotonia-speech impairment-severe cognitive delay syndrome ORPHA:371364","1/102",0.225832006978328,0.244619063633053,0,0,4.01070923418872,5.96779050603106,"GFAP"
"Postaxial polydactyly type B ORPHA:93335","1/102",0.225832006978328,0.244619063633053,0,0,4.01070923418872,5.96779050603106,"CACHD1"
"Autosomal dominant hypocalcemia ORPHA:428","1/102",0.225832006978328,0.244619063633053,0,0,4.01070923418872,5.96779050603106,"TMEM37"
"Prader-Willi syndrome due to imprinting mutation ORPHA:177910","1/102",0.225832006978328,0.244619063633053,0,0,4.01070923418872,5.96779050603106,"BEX1"
"Infantile myofibromatosis ORPHA:2591","1/102",0.225832006978328,0.244619063633053,0,0,4.01070923418872,5.96779050603106,"CD248"
"Familial porphyria cutanea tarda ORPHA:443062","1/102",0.225832006978328,0.244619063633053,0,0,4.01070923418872,5.96779050603106,"SLC25A20"
"Multiple epiphyseal dysplasia due to collagen 9 anomaly ORPHA:166002","1/102",0.225832006978328,0.244619063633053,0,0,4.01070923418872,5.96779050603106,"B3GAT1"
"Proteus syndrome ORPHA:744","1/102",0.225832006978328,0.244619063633053,0,0,4.01070923418872,5.96779050603106,"GRAMD4"
"Proximal symphalangism ORPHA:3250","1/102",0.225832006978328,0.244619063633053,0,0,4.01070923418872,5.96779050603106,"ADAMTS6"
"Isolated ectopia lentis ORPHA:1885","1/102",0.225832006978328,0.244619063633053,0,0,4.01070923418872,5.96779050603106,"CD248"
"Townes-Brocks syndrome ORPHA:857","1/102",0.225832006978328,0.244619063633053,0,0,4.01070923418872,5.96779050603106,"CACHD1"
"NON RARE IN EUROPE: Asperger syndrome ORPHA:1162","1/102",0.225832006978328,0.244619063633053,0,0,4.01070923418872,5.96779050603106,"B3GAT1"
"Autosomal recessive progressive external ophthalmoplegia ORPHA:254886","1/102",0.225832006978328,0.244619063633053,0,0,4.01070923418872,5.96779050603106,"GRAMD4"
"NON RARE IN EUROPE: Metabolic syndrome ORPHA:411969","1/103",0.22777734539855,0.244619063633053,0,0,3.97118847539016,5.87492334394335,"CACHD1"
"46,XX ovotesticular disorder of sex development ORPHA:2138","1/103",0.22777734539855,0.244619063633053,0,0,3.97118847539016,5.87492334394335,"GPT2"
"Neonatal glycine encephalopathy ORPHA:289857","1/103",0.22777734539855,0.244619063633053,0,0,3.97118847539016,5.87492334394335,"GPT2"
"Weill-Marchesani syndrome ORPHA:3449","1/103",0.22777734539855,0.244619063633053,0,0,3.97118847539016,5.87492334394335,"CD248"
"Butterfly-shaped pigment dystrophy ORPHA:99001","1/103",0.22777734539855,0.244619063633053,0,0,3.97118847539016,5.87492334394335,"CACHD1"
"Zimmermann-Laband syndrome ORPHA:3473","1/103",0.22777734539855,0.244619063633053,0,0,3.97118847539016,5.87492334394335,"GFAP"
"Hereditary elliptocytosis ORPHA:288","1/103",0.22777734539855,0.244619063633053,0,0,3.97118847539016,5.87492334394335,"DEFA1"
"Duane retraction syndrome ORPHA:233","1/103",0.22777734539855,0.244619063633053,0,0,3.97118847539016,5.87492334394335,"CACHD1"
"Alport syndrome-intellectual disability-midface hypoplasia-elliptocytosis syndrome ORPHA:86818","1/103",0.22777734539855,0.244619063633053,0,0,3.97118847539016,5.87492334394335,"POLR3G"
"Alveolar rhabdomyosarcoma ORPHA:99756","1/103",0.22777734539855,0.244619063633053,0,0,3.97118847539016,5.87492334394335,"CACHD1"
"Angelman syndrome due to imprinting defect in 15q11-q13 ORPHA:411515","1/103",0.22777734539855,0.244619063633053,0,0,3.97118847539016,5.87492334394335,"LRRN3"
"Pendred syndrome ORPHA:705","1/103",0.22777734539855,0.244619063633053,0,0,3.97118847539016,5.87492334394335,"GFAP"
"Autosomal dominant cutis laxa ORPHA:90348","1/103",0.22777734539855,0.244619063633053,0,0,3.97118847539016,5.87492334394335,"CD248"
"Familial hypercholanemia ORPHA:238475","1/103",0.22777734539855,0.244619063633053,0,0,3.97118847539016,5.87492334394335,"TMEM37"
"Preeclampsia ORPHA:275555","1/103",0.22777734539855,0.244619063633053,0,0,3.97118847539016,5.87492334394335,"MPPED2"
"Familial papillary or follicular thyroid carcinoma ORPHA:319487","1/103",0.22777734539855,0.244619063633053,0,0,3.97118847539016,5.87492334394335,"TMEM37"
"Autosomal dominant secondary polycythemia ORPHA:247511","1/103",0.22777734539855,0.244619063633053,0,0,3.97118847539016,5.87492334394335,"TMEM37"
"Isolated Klippel-Feil syndrome ORPHA:2345","1/103",0.22777734539855,0.244619063633053,0,0,3.97118847539016,5.87492334394335,"CD248"
"Renal tubular dysgenesis of genetic origin ORPHA:97369","1/104",0.229717893074581,0.244619063633053,0,0,3.93243510996632,5.78423168094792,"TMEM37"
"Hereditary hemorrhagic telangiectasia ORPHA:774","1/104",0.229717893074581,0.244619063633053,0,0,3.93243510996632,5.78423168094792,"CD248"
"COFS syndrome ORPHA:1466","1/104",0.229717893074581,0.244619063633053,0,0,3.93243510996632,5.78423168094792,"ADAMTS6"
"Sheldon-Hall syndrome ORPHA:1147","1/104",0.229717893074581,0.244619063633053,0,0,3.93243510996632,5.78423168094792,"CD248"
"Early-onset anterior polar cataract ORPHA:98988","1/104",0.229717893074581,0.244619063633053,0,0,3.93243510996632,5.78423168094792,"TMEM37"
"Alternating hemiplegia of childhood ORPHA:2131","1/104",0.229717893074581,0.244619063633053,0,0,3.93243510996632,5.78423168094792,"GFAP"
"Atypical glycine encephalopathy ORPHA:289863","1/104",0.229717893074581,0.244619063633053,0,0,3.93243510996632,5.78423168094792,"GPT2"
"Infantile glycine encephalopathy ORPHA:289860","1/104",0.229717893074581,0.244619063633053,0,0,3.93243510996632,5.78423168094792,"GPT2"
"Familial or sporadic hemiplegic migraine ORPHA:569","1/104",0.229717893074581,0.244619063633053,0,0,3.93243510996632,5.78423168094792,"GFAP"
"Uveal melanoma ORPHA:39044","1/105",0.231653661546854,0.244619063633053,0,0,3.89442700156986,5.69564568108454,"GRAMD4"
"Nanophthalmos ORPHA:35612","1/105",0.231653661546854,0.244619063633053,0,0,3.89442700156986,5.69564568108454,"GFAP"
"Dravet syndrome ORPHA:33069","1/105",0.231653661546854,0.244619063633053,0,0,3.89442700156986,5.69564568108454,"GFAP"
"Atypical Rett syndrome ORPHA:3095","1/105",0.231653661546854,0.244619063633053,0,0,3.89442700156986,5.69564568108454,"GFAP"
"Familial cerebral saccular aneurysm ORPHA:231160","1/105",0.231653661546854,0.244619063633053,0,0,3.89442700156986,5.69564568108454,"CD248"
"Autosomal dominant macrothrombocytopenia ORPHA:140957","1/105",0.231653661546854,0.244619063633053,0,0,3.89442700156986,5.69564568108454,"DEFA1"
"Primary hypereosinophilic syndrome ORPHA:314950","1/105",0.231653661546854,0.244619063633053,0,0,3.89442700156986,5.69564568108454,"CD248"
"NON RARE IN EUROPE: Heterozygous familial hypercholesterolemia ORPHA:406","1/106",0.23358466235033,0.244619063633053,0,0,3.85714285714286,5.60909836773195,"TMEM37"
"Lennox-Gastaut syndrome ORPHA:2382","1/107",0.235510907008418,0.244619063633053,0,0,3.82056218713901,5.52452548143668,"B3GAT1"
"Early-onset autosomal dominant Alzheimer disease ORPHA:1020","1/107",0.235510907008418,0.244619063633053,0,0,3.82056218713901,5.52452548143668,"GRAMD4"
"Pituitary stalk interruption syndrome ORPHA:95496","1/107",0.235510907008418,0.244619063633053,0,0,3.82056218713901,5.52452548143668,"CACHD1"
"Autosomal dominant nocturnal frontal lobe epilepsy ORPHA:98784","1/107",0.235510907008418,0.244619063633053,0,0,3.82056218713901,5.52452548143668,"B3GAT1"
"Myoclonic-astatic epilepsy ORPHA:1942","1/107",0.235510907008418,0.244619063633053,0,0,3.82056218713901,5.52452548143668,"GFAP"
"Generalized epilepsy with febrile seizures-plus ORPHA:36387","1/108",0.237432406982674,0.245935495937977,0,0,3.78466526797635,5.44186534675464,"GFAP"
"Septopreoptic holoprosencephaly ORPHA:280195","1/113",0.246969136476027,0.253025600313314,0,0,3.61479591836735,5.05526282536401,"CACHD1"
"Lobar holoprosencephaly ORPHA:93924","1/113",0.246969136476027,0.253025600313314,0,0,3.61479591836735,5.05526282536401,"CACHD1"
"Alobar holoprosencephaly ORPHA:93925","1/113",0.246969136476027,0.253025600313314,0,0,3.61479591836735,5.05526282536401,"CACHD1"
"Midline interhemispheric variant of holoprosencephaly ORPHA:93926","1/113",0.246969136476027,0.253025600313314,0,0,3.61479591836735,5.05526282536401,"CACHD1"
"Semilobar holoprosencephaly ORPHA:220386","1/114",0.248862407858827,0.25358337494558,0,0,3.58262597074228,4.98291365340615,"CACHD1"
"Microform holoprosencephaly ORPHA:280200","1/114",0.248862407858827,0.25358337494558,0,0,3.58262597074228,4.98291365340615,"CACHD1"
"Infantile spasms syndrome ORPHA:3451","1/115",0.250751014138588,0.254817246800295,0,0,3.55102040816327,4.9121080927455,"GFAP"
"Early infantile epileptic encephalopathy ORPHA:1934","1/116",0.252634966589978,0.256039750506285,0,0,3.51996450754215,4.84280114390583,"GFAP"
"Kallmann syndrome ORPHA:478","1/120",0.260124462166282,0.262921499393876,0,0,3.40096038415366,4.57971645890887,"CACHD1"
"Autosomal dominant non-syndromic intellectual disability ORPHA:178469","1/133",0.283960903877272,0.286244771736875,0,0,3.06400742115028,3.85733627834156,"KCNQ5"
"Autosomal dominant non-syndromic sensorineural deafness type DFNA ORPHA:90635","1/145",0.305294838614257,0.306927431334119,0,0,2.80697278911565,3.33040945482965,"TMC1"
"Autosomal recessive non-syndromic sensorineural deafness type DFNB ORPHA:90636","1/172",0.351044425036804,0.351980543503569,0,0,2.36054421768708,2.47111800186849,"TMC1"
"Retinitis pigmentosa ORPHA:791","1/174",0.354313300273642,0.354313300273642,0,0,2.3330187566356,2.42067896936234,"FSCN2"
